Closing the data loop in AI-driven drug discovery

Closing the data loop in AI-driven drug discovery. Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage.

A apuração publicada por www.technologyreview.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law.

• Ponto de atenção: closing.
• Ponto de atenção: data.
• Ponto de atenção: loop.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Tech.